HIV genotyping is a laboratory test used to identify genetic changes in HIV that may reduce the effectiveness of antiretroviral medications. It helps healthcare professionals understand drug resistance patterns and make informed treatment decisions. Learning about HIV genotyping provides insight into resistance testing, treatment selection, viral suppression, and the importance of monitoring changes in the virus over time.
HIV treatment has advanced significantly through the development of antiretroviral therapy (ART), which helps control viral replication and supports long-term health. However, HIV can develop genetic changes that reduce its sensitivity to certain medications. This process is known as antiretroviral drug resistance. HIV genotyping is an important laboratory approach used to identify these changes and understand which medications may be less effective. The information helps healthcare professionals evaluate treatment options, particularly when a person experiences treatment failure or has previously received antiretroviral medications.
HIV genotyping is a laboratory test that examines specific regions of the virus's genetic material to identify mutations associated with antiretroviral drug resistance. HIV reproduces rapidly and can develop genetic variations during replication. Some mutations allow the virus to continue multiplying even when a person is taking certain medications.
The test generally examines the HIV genes responsible for producing proteins targeted by antiretroviral drugs. These commonly include the reverse transcriptase, protease, and integrase genes. Changes in these regions can affect how effectively particular medications work.
Healthcare professionals may recommend resistance testing in different situations, including when a person is newly diagnosed, experiences an unexpected increase in viral load, or needs a change in treatment because the current combination is not controlling the virus effectively.
Important aspects of HIV genotyping include:
Mutation identification: Detects genetic changes associated with resistance to specific antiretroviral medications.
Treatment evaluation: Helps healthcare professionals understand whether existing medications remain effective.
Resistance patterns: Identifies mutations that may influence sensitivity to one or more drug classes.
Treatment planning: Provides laboratory information that supports decisions about appropriate medication combinations.
Monitoring treatment failure: Helps investigate why viral suppression has not been achieved or maintained.
Genotyping results are generally interpreted alongside viral load measurements, treatment history, medication adherence, and other clinical information. A detected mutation does not automatically mean that every medication within a particular drug class will be ineffective.
Antiretroviral drug resistance occurs when genetic changes in HIV reduce the ability of medications to prevent viral replication. Resistance can develop when HIV continues multiplying while exposed to antiretroviral medications, particularly when treatment levels are inconsistent or a treatment combination is not sufficiently effective.
There are different forms of HIV drug resistance. Transmitted resistance occurs when a person acquires HIV that already contains resistance-associated mutations. Acquired resistance develops after infection, often during treatment when viral replication continues under medication pressure. Cross-resistance can occur when a mutation reduces sensitivity to multiple medications within the same drug class or, in some cases, across related drugs.
Several laboratory approaches help healthcare professionals evaluate these resistance patterns.
Genotypic resistance testing identifies mutations in HIV genetic material. It is commonly used because it provides information about known resistance-associated changes.
Phenotypic resistance testing evaluates how effectively HIV grows in the presence of different antiretroviral medications under laboratory conditions. It measures the virus's actual susceptibility to particular drugs and may be useful in complex resistance cases.
Viral load testing measures the amount of HIV RNA in the blood. Although it does not directly identify resistance mutations, it helps determine whether treatment is successfully suppressing viral replication.
Important considerations when interpreting resistance testing include:
Treatment history: Previous and current antiretroviral medications help explain possible resistance patterns.
Testing timing: Resistance testing is generally most informative while a person is taking the failing treatment or shortly after discontinuation, as resistant viral populations may become less detectable over time.
Combination therapy: HIV treatment usually involves multiple medications that target different stages of viral replication.
Medication adherence: Consistent medication use is important for maintaining effective drug levels and reducing the risk of resistance.
Clinical interpretation: Test results must be evaluated by qualified healthcare professionals before treatment changes are considered.
HIV genotyping plays an important role in understanding how genetic changes influence antiretroviral treatment effectiveness. By identifying resistance-associated mutations and evaluating laboratory findings alongside viral load and treatment history, healthcare professionals can make informed decisions about treatment options and ongoing monitoring.